Bill of Health

JANUARY 12, 2023

In 2005, they published their research and insights in a series of research papers and also filed a patent application disclosing this modification (which eventually issued as patent no. Moderna also licensed their mRNA technology from Cellscript LLC – University of Pennsylvania’s successor-in-interest to the 966 patent.

COVID-19 Vaccine 319

COVID-19 Vaccine COVID-19 Licensing Governance 319

Bill of Health

OCTOBER 31, 2022

Some COVID-19 vaccine manufacturers in the US have refused to share vaccine samples for research purposes , creating an access issue with the potential to delay comparator studies, follow-on research, and new vaccine / drug development. By Aparajita Lath. This problem is not new in the biotechnology sector.

COVID-19 174

COVID-19 COVID-19 Vaccine Licensing FDA 174

Drug & Device Law

JANUARY 4, 2024

So we do have comments on the bizarre complaint that the Texas attorney general recently filed over COVID-19. The complaint, brought under the Texas consumer protection statute, sued a major manufacturer of COVID-19 vaccine that was used to control the recent pandemic. 247d-6d(b)(8). distribution, sale, . .

COVID-19 Vaccine 59

COVID-19 Vaccine COVID-19 FDA Public Health 59